Company Overview
Snapshot
Founded in January 2015 by Barak Katz, AntisepTech operates with 1–10 employees. The company has raised $150,000 across one funding round from two investors. In January 2018, AntisepTech secured a grant from the Israel Innovation Authority and R&D Authority, Rabin-MC.
Business overview
AntisepTech is a digital health startup that develops a patented technology to prevent infections and reduce the spread of germs and viruses. The company's core product utilizes smartphone technology to create real-time interactive heatmaps of hand contact, pinpointing potential locations of germs within patient rooms. This solution aims to enhance awareness, create safer environments, and improve patient experiences. AntisepTech serves the healthcare industry, focusing on hospitals, and operates within the Digital Healthcare sector, leveraging artificial intelligence, machine learning, and augmented reality to monitor hand hygiene practices in compliance with CDC and WHO recommendations.
Company Intelligence Q&A
- Who founded AntisepTech and when was it established?
- AntisepTech was founded in January 2015 by Barak Katz, who also serves as the CEO.
- What is AntisepTech's primary focus?
- AntisepTech focuses on developing a digital platform for infectious disease prevention, helping health organizations reduce infections and improve safety for patients, families, and healthcare workers.
- What technology does AntisepTech utilize in its solution?
- AntisepTech's patented technology uses users' smartphones to provide real-time interactive heatmaps of hand contact, pinpointing suspected locations of germs and viruses within patient rooms. This integrates artificial intelligence, machine learning, and augmented reality.
- Which markets does AntisepTech target?
- AntisepTech targets the healthcare market, specifically hospitals, with a focus on patient engagement and monitoring solutions in North America, Europe, and Asia.
- What was a key early funding event for AntisepTech?
- In January 2018, AntisepTech secured a grant totaling $150,000 from the Israel Innovation Authority and R&D Authority, Rabin-MC.